MDUK Oxford Neuromuscular Centre

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Spinal muscular atrophy

Running trials

• Recruiting

  A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy

  NCT07287982· Phase 2· argenx· Source

  Contact: Laurent Servais

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Spinal muscular atrophy1 recruiting